A case of esophageal small cell carcinoma with syndrome of inappropriate antidiuretic hormone secretion

Japanese Journal of Cancer and Chemotherapy

Volumn 37, Issue 10, 2010, Pages 1941-1944

  Kanzaki, Masaki ^a   Muto, Yuta ^a   Yoshinouchi, Satoshi ^a   Maeda, Mamoru ^a   Miyoshi, Shunsaku ^a   Teshima, Shinichi ^a  

^a Doai Kinen Hospital   (Japan)

Author keywords

Esophageal cancer; Oat cell carcinoma; SIADH

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; IRINOTECAN; PACLITAXEL; SODIUM;

AGED; ARTICLE; BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPY; ESOPHAGUS CARCINOMA; HUMAN; INAPPROPRIATE VASOPRESSIN SECRETION; LYMPH NODE; MALE; SMALL CELL CARCINOMA; SODIUM BLOOD LEVEL; TREATMENT RESPONSE;

EID: 79960831475     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Hudson E, Powell J, Mukherjee S, et al: Small cell oesophageal carcinoma: an institutional experience and review of the literature. Br J Cancer 96(5): 708-711, 2007. (Pubitemid 46376619)
2. Lv J, Liang J, Wang J, et al: Primary small cell carcinoma of the esophagus. J Thorac Oncol 3(12): 1460-1465, 2008.
3. Gastroenterol Endosc 38(10): 2407-2413, 1996.
4. Chin K, Baba S, Hosaka H, et al: Irinotecan plus cisplatin for therapy of small-cell carcinoma of the esophagus: report of 12 cases from single institution experience. Jpn J Clin Oncol 38(6): 426-431, 2008. (Pubitemid 351965947)
5. Noda K, Nishiwaki Y, Kawahara M, et al: Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 346(2): 85-91, 2002. (Pubitemid 34438898)